# A Dose-Finding Study of E7050 Administered Orally to Patients With Advanced Solid Tumors

> **NCT00869895** · PHASE1 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 60 (actual)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** E7050

## Key facts

- **NCT ID:** NCT00869895
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2012-08
- **Final completion:** —
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2016-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00869895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00869895, "A Dose-Finding Study of E7050 Administered Orally to Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00869895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*